Item — HN Reader

Incredibly stupid this is allowed and will become an avenue for rampant insider trading by biotech employees.

Look at the recent ChemoCentryx fraud where they settled for $35 million over misleading data and overstating results. This is going to encourage even more data manipulation.

1 comments

> rampant insider trading by biotech employees

It also provides a big incentive for sabotage.

This is one of the huge problems with allowing betting. Of course, people could collude without the formal marketplace, but just as social media provides really painful detrimental cons along with its pros, so do betting platforms.